D&D Pharmatech (XKRX:347850) Pretax Margin % : -430.31% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. D&D Pharmatech's Pre-Tax Income for the three months ended in Sep. 2024 was ₩-8,347 Mil. D&D Pharmatech's Revenue for the three months ended in Sep. 2024 was ₩1,940 Mil. Therefore, D&D Pharmatech's pretax margin for the quarter that ended in Sep. 2024 was -430.31%.

The historical rank and industry rank for D&D Pharmatech's Pretax Margin % or its related term are showing as below:

XKRX:347850' s Pretax Margin % Range Over the Past 10 Years
Min: -26780.48 Med: -5516.92 Max: 24.06
Current: -235.82

XKRX:347850's Pretax Margin % is ranked worse than
57.47% of 1004 companies
in the Biotechnology industry
Industry Median: -145.995 vs XKRX:347850: -235.82

D&D Pharmatech Pretax Margin % Historical Data

The historical data trend for D&D Pharmatech's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Pretax Margin % Chart

D&D Pharmatech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

Get a 7-Day Free Trial

-5,281.64

-26,780.48

24.06

D&D Pharmatech Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Pretax Margin %	Get a 7-Day Free Trial			197.47	-2.40	10.97	-265.31	-430.31

Competitive Comparison of D&D Pharmatech's Pretax Margin %

For the Biotechnology subindustry, D&D Pharmatech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

D&D Pharmatech's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D&D Pharmatech's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where D&D Pharmatech's Pretax Margin % falls into.

D&D Pharmatech Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

D&D Pharmatech's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	4494.47	/	18677.046
	=	24.06 %

D&D Pharmatech's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-8346.842	/	1939.728
	=	-430.31 %

D&D Pharmatech (XKRX:347850) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

D&D Pharmatech Pretax Margin % Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

D&D Pharmatech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR

Website

http://www.ddpharmatech.com

D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech Headlines

No Headlines